Effectiveness and Safety of Eribulin for Human Epidermal Growth Factor Receptor 2 Negative Metastatic Breast Cancer in a Real-World Population.
Journal of oncology pharmacy practice(2021)
Key words
Eribulin,human epidermal growth factor receptor-2 negative,metastatic breast cancer,capecitabine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined